The Lancet Group
+2
2213-8587
Monthly
44·0
2013
18888347287
YES
United Kingdom
English
YES
Google Scholar
editorial@lancet.com, pressoffice@lancet.com, MKoch@lancet.com
The Lancet Diabetes & Endocrinology is an independent journal with an international perspective and a strong clinical focus. Each monthly issue features original clinical research, expert reviews, news, and provocative comment and opinion in diabetes and endocrinology, providing a clear, independent perspective about the clinical advances and practice-changing research shaping your specialty globally. We publish papers that reflect the rich variety of ongoing clinical research in these fields, especially in the areas of diabetes, obesity, nutrition and metabolism, osteoporosis, adrenal disorders, bone metabolism, growth disorders, lipid disorders, neuroendocrinology, paediatric endocrinology, pituitary disorders, reproductive endocrinology, and thyroid disorders. We consider any original research contribution that advocates change in or illuminates clinical practice, and informative reviews, on any topic connected with diabetes, diabetes-related non-communicable diseases, endocrinology, and metabolism. We have a special interest in studies on these topics of global health importance and with relevance to health in low-income and middle-income countries. We do not consider reports that include results of experiments on non-human animals. We publish a range of content types including Articles, Review, Comment, Correspondence, Health Policy, and Personal View about diabetes, endocrinology, and metabolism. We also publish Series and Commissions that aim to shape and drive positive change in clinical practice and health policy in areas of need in diabetes and endocrinology. Learn more about the types of papers we publish.
Background Diabetes, particularly type 1 diabetes, at younger ages can be a largely preventable cause of death with the correct health care and services. We aimed to evaluate diabetes morta...
Background Odanacatib, a cathepsin K inhibitor, reduces bone resorption while maintaining bone formation. Previous work has shown that odanacatib increases bone mineral density in postmenop...
OJSCloud offers a complete, free setup to get you publishing.
Start Your Free Journal!Scholar9.com is a peer-review platform that hosts journals from across the globe. Please note that we do not own any of the journals hosted on the platform.
Our platform enables journal owners to send articles for peer review to users who have registered via https://scholar9.com/register and have consented to serve as reviewers for multiple journals. Additionally, we offer an indirect manuscript submission system for journals that are claimed and actively managed by their respective owners on Scholar9.com.
For accurate information about the indexing status of journals (in databases such as UGC CARE, Scopus, or Web of Science) and contact details, users must refer to the respective official websites.
Scholar9 is not responsible for indexing claims, manuscript acceptance/rejection, refunds of article processing charges, or any stage of the final publication process. Users are strongly advised to verify all information provided on the platform independently.
Scholar9.com disclaims liability for disputes related to indexing claims, publication decisions, or other journal-specific matters. Users are encouraged to contact the respective journal owners directly for detailed information and clarifications.